|
EP3091359A1
|
|
Method for identifying marker proteins for diagnosis and risk stratification of blood coagulation disorders
|
|
WO2015176951A1
|
|
Method for the quantitative analysis of organic molecules in a sample
|
|
DE102014115702B3
|
|
Detector for investigations in an electromagnetic or magnetic field
|
|
WO2015032954A2
|
|
Biomarkers for cholangiocellular carcinoma (ccc)
|
|
DE102014112270B3
|
|
Method for measuring platelet function
|
|
DE102014110544B3
|
|
Device for taking a sample and feeding it into an analytical evaluation system
|
|
DE102014107296B3
|
|
Probe for nuclear magnetic resonance spectroscopy
|
|
DE102014104511A1
|
|
Method and device for the non-invasive determination of process parameters in multiphase flows
|
|
DE102013108321B3
|
|
Fresnel parallelepiped
|
|
EP2867678A2
|
|
Marker sequences for parkinson's disease and use thereof
|
|
EP2864791A2
|
|
Specific biomarkers for hepatocellular carcinoma (hcc)
|
|
DE102012101019A1
|
|
Spectrometer arrangement for UV-VIS
|
|
DE102007000988A1
|
|
Method for measuring time-modulated spectra
|
